Analyst firms · BTIG · OBIO

BTIG OBIO price target and rating history

Orchestra BioMed Holdings Inc. (OBIO) · Health Care

BTIG rates Orchestra BioMed Holdings Inc. (OBIO) Buy with a $10 price target, as of its latest action on Sep 10, 2026. It has published 3 rating actions on OBIO since March 2025, including 1 upgrade and 1 downgrade.

Current rating
Buy
Price target
$10
Median target, all firms
Too few
Actions on OBIO
3

BTIG price target on OBIO

$12$11$102026
BTIG price target on OBIO, each point a stated target, March 2025 to September 2026.

Every BTIG rating on OBIO

How other firms rate OBIO

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
BTIGBuy$10Sep 10, 2026
TD CowenBuy$15Dec 10, 2025

Questions about BTIG and OBIO

What is BTIG's price target for OBIO?
BTIG's latest stated price target for Orchestra BioMed Holdings Inc. (OBIO) is $10, from its action on Sep 10, 2026.
What is BTIG's rating on OBIO?
BTIG rates OBIO Buy, a bullish rating, as of Sep 10, 2026.
When did BTIG last change its view on OBIO?
On Sep 10, 2026, BTIG upgrades to Buy from Neutral, price target $10.

All BTIG ratingsOBIO news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.